Announcements Trials
Browse Landscape

Phase

Phase 1 119Phase NA 51Phase 1/2 15Phase 2 6Phase 3 3Phase 4 2Phase 2/3 2

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Conditions

Breast Neoplasms 1128Carcinoma, Non-Small-Cell Lung 718Neoplasms 545Prostatic Neoplasms 502Colorectal Neoplasms 438Multiple Myeloma 336Lung Neoplasms 309Neoplasm Metastasis 288Leukemia, Myeloid, Acute 263Stomach Neoplasms 248Carcinoma, Hepatocellular 245Ovarian Neoplasms 225Rectal Neoplasms 211Colonic Neoplasms 204Lymphoma, Follicular 200Lymphoma 199Leukemia 190Uterine Cervical Neoplasms 181Head and Neck Neoplasms 174Pancreatic Neoplasms 171Lymphoma, Non-Hodgkin 167Leukemia, Lymphocytic, Chronic, B-Cell 166Lymphoma, Large B-Cell, Diffuse 163Recurrence 161Melanoma 158Precursor Cell Lymphoblastic Leukemia-Lymphoma 154Squamous Cell Carcinoma of Head and Neck 147Pain 141Urinary Bladder Neoplasms 139Brain Neoplasms 133

Interventions

Quality of Life 1Patient Readmission 1Palliative Care 1Olanzapine 1Nivolumab 1Needs Assessment 1Coping Skills 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Advanced Cancer × Clear all
NCT02743494 2025-11-18

CheckMate 577

Bristol-Myers Squibb

Phase 3 Completed
794 enrolled 13 charts 1 FDA

Advanced Cancer

NCT06338683 2024-03-29

Survival With Olanzapine in Patients With Locally Advanced or Metastatic Upper Gastrointestinal and Lung Cancer

Qinghai Red Cross Hospital

Phase 3 Recruiting
230 enrolled

Advanced Cancer

NCT01444157 2014-07-18

FamCope

Bispebjerg Hospital

Phase 3 Completed
700 enrolled

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡